Collegium Pharmaceutical, Inc (COLL): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Older than the company's other figures. The latest EBITDA is for the year ended 2019-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$23.02M

Year ended 2019-12-31

2014-12-31 EBITDA (USD) 2019-12-31

Period ended	EBITDA	Change YoY	Source filing
2019-12-31	-$23.02M	n/m	2022-02-24, From 2019-01-01
2018-12-31	-$19.61M	n/m	2021-02-25, From 2018-01-01
2017-12-31	-$74.85M	n/m	2020-02-27, From 2017-01-01
2016-12-31	-$93.43M	n/m	2019-02-27, From 2016-01-01
2015-12-31	-$26.74M	n/m	2018-03-07, From 2015-01-01
2014-12-31	-$17.48M	n/a	2017-03-10, From 2014-01-01